Precigen (PGEN) Assets (2012 - 2026)
Precigen (PGEN) reported Assets of $138.6 million for Q1 2026, up 7.64% year-over-year from $128.8 million in Q1 2025, and down 10.85% quarter-over-quarter from $155.5 million in Q4 2025.
Precigen (PGEN) Assets (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Assets data on file, last reported at $138.6 million in Q1 2026.
- Assets for Q1 2026 came in at $138.6 million, up 7.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $138.6 million (up 7.64% YoY), and the FY2025 annual result was $155.5 million, up 7.05% from the prior year.
- Assets eased to $138.6 million in Q1 2026 per PGEN's latest filing, from $155.5 million in the prior quarter.
- Over five years, Assets peaked at $335.6 million in Q1 2022 and troughed at $73.2 million in Q2 2024.
- A 5-year average of $179.7 million and a median of $155.5 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets sank 64.75% in 2024, then soared 105.17% in 2025.
- A 5-year view of Assets shows it stood at $216.0 million in 2022, then sank by 30.07% to $151.0 million in 2023, then slipped by 3.82% to $145.3 million in 2024, then gained by 7.05% to $155.5 million in 2025, then fell by 10.85% to $138.6 million in 2026.
- Business Quant data shows PGEN's Assets at $138.6 million in Q1 2026, $155.5 million in Q4 2025, and $171.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 640.56 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 138.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.63 Mn |
| Dec 31, 2025 | 155.51 Mn |
| Sep 30, 2025 | 171.26 Mn |
| Jun 30, 2025 | 101.90 Mn |
| Mar 31, 2025 | 128.79 Mn |
| Dec 31, 2024 | 145.27 Mn |
| Sep 30, 2024 | 83.47 Mn |
| Jun 30, 2024 | 73.16 Mn |
| Mar 31, 2024 | 134.85 Mn |
| Dec 31, 2023 | 151.04 Mn |
| Sep 30, 2023 | 190.69 Mn |
| Jun 30, 2023 | 207.53 Mn |
| Mar 31, 2023 | 241.55 Mn |
| Dec 31, 2022 | 215.98 Mn |
| Sep 30, 2022 | 259.25 Mn |
| Jun 30, 2022 | 321.22 Mn |
| Mar 31, 2022 | 335.57 Mn |
| Dec 31, 2021 | 359.86 Mn |
| Sep 30, 2021 | 376.90 Mn |
| Jun 30, 2021 | 402.57 Mn |